Amoxicillin-clavulanic acid: An appropriate option for the management of pelvic inflammatory disease


eMediNexus    01 December 2017

A randomized multi centre trial conducted on 152 hospitalized females with pelvic inflammatory disease compared the outcomes of amoxicillin clavulanic acid with a regimen comprising three antimicrobial agents aminopenicillin an aminoglycoside and metronidazole . The results demonstrated that 96 patients had complete or partial response and no failures in the amoxicillin clavulanic acid group while the figure was 90 with the triple therapy regimen. Moreover there were 5 failures in the triple therapy group. Thus combination of amoxicillin clavulanic acid seems to be a good option for treating females with pelvic inflammatory disease.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.